Table Of Content

Brain Research Bulletin, Vol. 29, pp. 955-959, 1992 0361-9230/92 $5.00 + .00 Printed in the USA. All rights reserved. Copyright © 1992 Pergamon Press Ltd. BRAIN RESEARCH BULLETIN VOLUME 29 1992 SUBJECT INDEX AA nonresponder, 37 Binocularity, 541 Cross-sensitization, 675 AA responder, 37 Bladder, 651 Culture, 795 Abbreviated atlas, 703 Blood-brain barrier, 257 Cyclic AMP, 289 Absence epilepsy, 515 Blood flow, 303 Cyprinus carpio, 529 Accessory olfactory bulb, 209 Body temperature, 27, 189 Cytoarchitecture, 95 Acetylcholine, 449, 667 Body weight, 147, 355, 909 Cytokine(s), 27, 221 ACTH, 37, 129 Botulinum neurotoxin, 917 Activation, 949 Brain, 449 Dapiprazole, 401 Activity, 843 Brain cell differentiation, 441 DA release, 369 Activity-habituation test, 609 Brain function, 303 DBA/2, 337 Acupuncture analgesia, 37 Brain injury, 435 DBA/2J and C57BL/6J mice, 119 Acupuncture analgesia descending pain Brain slice, 285, 503, 767 Deep cerebellar nuclei, 329 inhibitory system, 617 Brainstem, 95, 141, 507, 605 Degeneration, 635, 831 Adenosine, 315 Brain weight, 337 6-receptor ACh release, 369 Adenosine cyclic monophosphate, 315 BXD recombinant inbred strains, 337 Descending inhibitory system, 883 Adrenalectomy, 355 Descending noradrenergic system, 617 Adrenaline, 871 Calbindin D-28K, 783 Descending serotonergic system, 617 Adrenergic receptors, 265, 297 Calcium, 303, 499 Determination, 499 Affect, 303 Calcium binding, 783 Development, 7, 449 Afferent, 651 Calcium blocker, 519 Dexamethasone, 355 Afferent pathway, 37 Calcium-calmodulin dependent protein kinase, Dextrallorphan, 419 Aging, 459 949 Dietary selection, 355 Airflow, 69 Calcium channel, 221 Differentiation, 795 Air pressure, 69 Calcium current, 221 Di-o-tolyguanidine, 419 Alpha receptors, 871 cAMP, 285 Direct microscopy, 441 a-sialyl cholesterol, 795 Canine dorsal medulla, 813 Diuresis, 401 Alpidem, 905 CA1, 685 D1 and D2 receptors, 135 Amidine, 511 Carbon dioxide, 573 DOPAC/DA, 173 Amino acid uptake, 297 Castration, 897 Dopamine, 7, 147, 239, 247, 449, 473, 567, Amphetamine, 247, 401, 609 Cat, 381 675, 795, 843 Amygdala, 345, 511, 909 Catecholamines, 257, 479 Dopamine D, receptors, 469 Analgesia, 605, 859 Cathinone,843 Dopaminergic neuron, 691 Angiotensin II, 389, 553, 813 Caudate, 891 Dopaminergic transmission, 617 Animal hypnosis, 141 Caudate putamen, 193, 473 Dorsal medulla, 15, 703 Anorexia, 859 Central nervous system, 697 Dorsal motor nucleus of the vagus, 813 Anterior arcuate nucleus, 37 Cerebellum, 435 Dorsal raphe nucleus, 943 Anticonvulsant, 165 Cerebral ischemia, 395, 559, 659 Drinking, 401, 859 Anxiety, 381, 901 C57BL/6, 337 Drug disposition, 51 Arcuate nucleus of hypothalamus, 883 c-fos, 469 Dynorphin antiserum, 605 Area postrema, 95, 257, 703 CGP 42112A, 389 Dystonia, 329 Arginine vasopressin, 553 Chelonians, 427 Aspartic acid, 459 Choline acetyltransferase, | Asphyxia, 573 Cholinergic neurons, 479 Early exposure, | Astrocyte(s), 257, 265, 277, 297, 303, 315 Cholinergic receptor binding, 609 EEG, 837 Astrocyte cultures, 289 Cholinesterase inhibition, 179 EEG analysis, 909 AT-1 and AT-2 receptors, 389 Circumventricular organ, 257 Eight-arm maze, 363, 609 Audiogenic seizures, 119 c-jun, 469 Electrical stimulation, 925 Auricular acupuncture point, 157 CNS, 199 Electrolytic lesion, 125 Autonomic nervous system, 767 Cocaine, 51 Electronic camera lucida, 441 Autoradiography, 395, 599 Cognition, 303 EM autoradiography, 193 Autoxidation, 891 Common carotid artery, 685 Emotional stress, 135 AV3V, 581 Comparison of methods, 441 Endogenous opiate control, 369 Axon, 493 Computer, 499 Endogenous opioids, 859 Axon degeneration, 411 Computer-assisted imaging, 441 Endotoxin, 807 Computer simulation, 111 Energy metabolism, 303 Basal ganglia, 319 Conditioned reinforcement, 247, 675 Epilepsy, 119, 511 Behavior, 897 Conscious rat, 359 Epinephrine, 871 Benzodiazepine(s), 165, 905 Convergence, 773 Estrogen, 239 6-adrenergic receptor(s), 257, 277 Corpus callosum, 493, 541 Estrous cycle, 165 B-adrenoceptor(s), 257, 285 Cortex, 441 Ethanol, 173 B-endorphin, 37 Corticofugal projections, 925 Evoked potential, 37, 147 Beta-endorphin secretion, 553 Corticosterone, 355, 807 Evoked ventral root potentials, 15 Bicuculline, 581 Corticosterone prolactin, 129 Excitatory amino acids, 247, 581 Binocular visual fields, 427 Corticotropin releasing factor, 51, 567 Excitotoxicity, 243 955 956 Excitotoxins, 459 Immune system, 221 Mitral cell, 209 Exploration, 381 Immunocytochemistry, 329, 375, 479, 529, MK-801, 659 783, 821, 931 Model, 1 11 Facial nerve, 407 Immunohistochemistry, 199 Monkey(s), 685, 901 Fear, 381 Immunomodulator, 221 Monoamines, 529 Feeding, 355, 401, 525 Immunoprecipitation, 949 Morphine, 37, 401, 859 Fenfluramine, 859 Immunostaining, 943 Morphine analgesia, 617 Fever, 27, 189 Inbred mice, 337 Morris maze, 363 5HT,, antagonist, 901 Inferior mesenteric ganglion, 651 Morris water maze, | Fluorescent dyes, 407 Infraorbital nerve, 69 Motility, 135 Fluorocitrate, 285 Inhibition, 111, 949 Motor cortex, 319 Fluoro-gold, 635 Innocuous stimuli, 773 Motor neuron, 277 Fluoro-gold projections, 209 Inositol phosphate, | Mouse (Mus musculus), 411, 609 Fluphenazine, 473 Inositol triphosphate, 559 Multiple memory systems, 643 Follicle-stimulating hormone, 231 Insulin, 129 u-receptor, 369 Food intake, 909 Interleukin-1, 189, 221, 243, 807, 897 Muscarinic receptor(s), 1, 147, 363 Free radical(s), 699, 891 Interleukin-1l-receptor antagonist protein Myelin, 697 F344 rats, 459 (IRAP), 807 Myopathy, 179 Interpeduncular nucleus, 589 GABA, 57, 303, 329, 581, 943 Intestinal growth, 45 nAChR, 173 GABA/benzodiazepine receptors, 119 Intracellular recording, 767 NaCl appetite, 389 GABA receptors, 165 Intracerebroventricular, 75, 843 Na’ current, 691 Gamma-hydroxybutyrate, 845 Intracerebroventricular injection, 525 Naloxone, 401 Ganglioside, 795 Intravenous administration, 51 NBM.-lesioned rats, 847 Gel chromatography, 45 In vitro, 879 Needling, 147 Gene expression, 589 Ipsilateral visual projections, 427 Nematode, 667 Gene-induced pathology, 411 Ischemia, 243, 519 Neonatal exposure, 363 Gene mapping, 337 Ischemia neuronal damage, 659 Neophobia, 609 Gerbil, 395, 559, 659 Ischemic cell changes, 519 Neophopia, 345 Glia, 265, 277 Isoproterenol, 289 Neostriatum, 319, 359 Glial fibrillary acidic protein, 289 Nervous system, 221 Globus pallidus, 193, 319 Kainic acid, 285, 459, 909 Neural transplantation, 147 Glossopharyngeal nerve, 407 Knee jerk, 15 Neurite outgrowth, 831 GLP-1(7-36) amide, 359 Neuroimmunology, 221 Glucagon-like immunoreactivity, 45 Lateral hypothalamic area, 767 Neuroleptic drugs, 469 Glucocorticoids, 355 Lateral hypothalamus, 157, 503 Neuromodulation, 315 Glucose, 503 Lateral tegmental cell groups, 931 Neuromuscular junction, 179 Glutamate, 303 Laterodorsal tegmental nucleus, 479 Neuronal activity in HVM, 617 Glutamic acid, 359 Learning, 345 Neuronal death, 635, 685 Glutamic acid decarboxylase, 329 Lesion, 375 Neuronal degeneration, 243 Glutamine, 359 LHRH, 75 Neurons, 303, 441 Glutathione, 699 Lipopolysaccharide, 807 Neuropeptide(s), 375, 529 Gonadectomy, 165 Lithium, 239 Neuropeptide Y, 859 Go/no-go discrimination, 643 Local application, 837 Neurotoxicity, 243 Growth, 449 Localization, 285 Neurotoxins, 635 Growth factor, 221 Locomotor activity, 173, 247 Neurotransmitter(s), 303, 659 Guinea pig, 199, 221, 767 Losartan, 389 Neurotransmitter systems, 395 Gustatory neocortex, 925 LTP, 847 Neurotropin, 767 Luteinizing hormone, 231 Newborn rat, 879 Haloperidol, 449, 473 Nicotine, 173, 363, 507 Hereditary nerve degeneration, 41 1 Magnocellular, 681 Nicotinic receptor, 589, 667 High affinity choline uptake, 147 Major pelvic ganglion, 651 NMDA receptors, 247 High resolution receptor autoradiography, 813 Male rat, 897 N-methyl-D-aspartate antagonist, 659 Hippocampal formation, 147, 519 Masseter muscle, 773 Nociceptive continuum, 507 Hippocampus, 1, 221, 363, 395, 559, 643, 659, Mating behavior, 75 Nociceptive reflex, 507, 605 685, 831, 847 Mecamylamine, 173 Nonacupuncture point stimulation-produced Histology, 441 Mechanoreceptor, 69 analgesia, 37 Historical concepts of astrocytes, 265 Medial arcuate nucleus, 37 Nonpeptide antagonists, 389 [>H]mazindol, 81 Medial geniculate nucleus, 193 Noradrenaline,303 HRP, 493, 821 Medial preoptic area, 125 Noradrenergic afferents, 931 Human, 95 Medial septum, 635, 643 Norepinephrine, 315, 435, 459, 567 Human brain, 441 Median eminence, 681 Noxious stimuli, 773 Hyperalgesia, 507, 605 Medullary pressor mechanisms, 15 Nucleus accumbens, 473, 843 Hyperphagia, 375 Metabolism, 573 Nucleus basilis magnocellularis, 345 Hyperthermia, 659 Methysergide, 141 Nucleus of the solitary tract, 95, 257 Hypoglossal nucleus, 931 MHPG, 807 Nucleus subceruleus, 931 Hypophysectomy, 37 Mice, 173, 363 Nucleus tractus solitarii, 407, 813 Hypothalamic-pituitary-adrenal axis, 51 Microdialysis, 285, 473, 837 Nucleus tractus solitarius, 703 Hypothalamic ventromedian necleus, 157 Microdissection, 859 Numerical densities, 441 Hypothalamus, 129, 231, 375, 553, 681, 807, Microiontophoresis, 909 853 Microneurography, 69 Obesity, 147, 853 Hypothermia, 659 Microvid, 441 Occlusion, 685 INDEX Odor stimulation, 111 Rat striatum, 369 Tail flick, 859 Olfaction, 111 Receptive fields, 541 Tardive dyskinesia, 473 Olfactory bulb, 111 Receptor(s), 303, 395, 905 Taste, 407, 925 Ontogeny and development, 407 Receptor antagonist, 221 Taste aversion, 345 Opioids, 27, 675 Receptor autoradiography, 659 Temporomandibular joint, 773 Optic nerve degeneration, 41 1 Receptor purification, 667 Tetanus neurotoxin, 917 Oral mucosa, 69 Receptor subtypes, 675 Tetrodotoxin, 179, 691 Oxygen, 573 Red nucleus, 419 Thermally evoked tail avoidance reflex, 507 Regulation, 553 Thermosensitive neurons, 27 Renal nerve activity, 573 3-acetylpyridine, 329 Pain, 605, 871 Respiratory neurons, 879 3-dimensional computer software, 441 Pain reactivity, 609 Restraint stress, 859 (+)-3-PPP, 419 Parabrachial pons, 925 Reticulogigantocellular nucleus, 617 Thyrotropin-releasing hormone (TRH), 821 Paradoxical sleep, 525 Reticuloparagigantocellular nucleus, 617 Tolerance, 395, 559 Paramedian reticular nucleus, 573 Retrograde labeling, 635 Tonic activity, 605 Paraventricular nucleus, 225, 681, 859 Retrovirus, 81 Tooth pulp stimulation, 883 Parietal cortex, 345 Rostral ventrolateral medulla, 879 Torus semicircularis, 529 Parkinson’s disease, 81, 699, 795, 891 Toxicity, 891 Parturation, 7 Saccharin and glucose, 859 Trachea, 821 Parvalbumin, 783 Saline/ethanol/propylene glycol, 515 Transient ischemia, 685 Parvocellular reticular nucleus, 15 Schedule-controlled behavior, 567 Transplantation, 81, 795 Patch clamp, 221 Sciatic nerve isografts, 831 Trigeminal subnucleus caudalis, 883 Pattern, 111 Scopolamine, 609 Trigeminal subnucleus interpolaris, 773 PD 123319, 389 Seasonal cycles, 225 Trophic factor, 795 (+)-Pentazocine, 419 Second messenger(s), 553, 559 Tryptophan, 807, 853 Periaqueductal gray (PAG), 871 Secretion, 315 Tryptophan hydroxylase, 949 Phenobarbitol, | Seizures, 459, 511, 837 Tumor necrosis factor, 807 Phorbol myristate acetate, 289 Selected mouse lines, 57 Tween-80, 515 Photoperiodism, 225, 231 Sensorimotor cortex, 435 Tyrosine, 567 Place navigation, 345 Sensory deprivation, 407 Tyrosine hydroxylase, 651, 931 Plus-maze, 381 Serotonin, 141, 303, 943 Polymorphism, 119 Sex difference, 493 Postembedding, 943 U-50,488H, 401 Sexual behavior, 125 Posterior arcuate nucleus, 617 Ultrastructure, 257, 821 Sialic acid, 795 Postnatal, 7 Unit neuronal activity, 503 Potassium, 303 Sigma receptors, 419 Unit recording, 541 Signal transduction, 659 Prazosin, 871 6-hydroxydopamine, 699 Preconditioning, 395, 559 Vagal preganglionic motoneuron, 821 Slow wave sleep, 525 Precursor, 567 Vasopressin, 681, 897 Social interaction, 381 Preembedding,943 Velopharyngeal closure, 69 Solvent, 515 Prenatal, 7 Ventral tegmental area, 691 Somatostatin release, 837 Prenatal benzodiazepine exposure, 609 Ventrolateral medulla, 15 Somatotropin, 853 Prenatal exposure, 363 Ventromedial hypothalamic lesioned rats, 45 Spatial navigation, 147 Preoptic area, 27 Ventromedial hypothalamic nucleus, 767 Spatial reference memory, 147 Primary culture, 297 Ventromedian nucleus of the hypothalamus, Spatial working memory, 147 Primate, 519, 685 Spike-triggered averaging, 879 617 Proepileptic potency, 515 Vimentin, 289 Spinal cord, 225 Program, 499 Visual cortex, 257, 493, 541 Spinal reflex, 15 Prolactin, 231 Vitamin E, 699 Stain, 697 Prostaglandins, 27 Voluntary movement, 141 Stereoscopic vision, 427 Protein kinase C, 289, 553 Vomeronasal organ, 75 Stereotyped behavior, 239 Purkinje cells, 329 Steroid(s), 57, 511 Push-pull, 359 Steroid hormones, 165 WAG /Rij inbred strain, 515 Push-pull perfusion, 859 Stress, 129, 567 Wallerian degeneration, 41 1 Pyridostigmine, 179 Striatum, 81, 147, 449, 469 Water balance, 581 Pyrogen, 189 Subfornical organ, 581 Water intake, 389 Substance P, 199 WGA-HRP, 209, 931 Quantification, 441 Substantia nigra, 843 Whole-cell patch clamp, 691 Quantitative trait loci (QTL), 337 Subthalamic nucleus, 319 Wind-up, 883 Quinones, 891 (S)-UH-301, 901 wl-Wabbler-lethal, 411 Superior colliculus, 589 Working memory, 643 R 5135, 511 Superoxide dismutase, 699 Rabbit, 821 Supersensitivity, 239 Yohimbine, 871 Radioimmunoassay, 837 Supraoptic dendrites, 209 Raphe magnus, 617 Sympathetic, 651 Rat(s), 135, 401, 407, 449, 493, 651, 773, 783, Synapse, 257, 277, 943 zif-268, 469 843 Synaptic interactions, 479 Zolpidem, 905 Rat diaphragm, 179 Synaptosomes, 917 Zopiclone, 905 AUTHOR INDEX Adams, R. N., 891 Curtis, R. L., 411 Ho, C. W., 573 Lin, M. T., 573 Adler, M., 179 Czurk6, A., 909 Holson, R. R., 449 Lin, R. H., 573 Afonso, D., 7 Holtzman, S. G., 859 Lin, R. T., 573 Agmo, A., 125 Dantzer, R., 897 Homma, I., 821, 879 Lin, Y. F., 15 Ahlers, S. T., 567 Dasgupta, B. R., 917 Hori, T., 767 Lorden, J. F., 329 Aijon, J., 783 Davis, B. J., 329 Howard, G., 75 Low, W. C., 147 Albin, R. L., 697 Dawson, Jr., R., 459 Hudson, C. S., 179 Lutes, J., 329 Aldes, L. D., 931 De Carolis, A. S., 847 Hyde, T. M., 95 Lynch, A. M., 199 Ali, S. F., 449 Delville, Y., 681 Alleva, E., 609 De Saint Hilaire, Z., 525 Ichikawa, N., 69 Martin, J. R., 901 Alonso, J. R., 783 Diaz, J., 407 Inoue, S., 45 Martin, R. J., 853 Angulo, J., 81 Dilorenzo, P. M., 925 Iwase, M., 821 Martin, W. R., 507, 605 Aoki, C., 257 Diz, D. I., 813 Iwatsuki, K., 821, 879 Matsumoto, R. R., 419 Arai, T., 37 Dollison, A., 81 McCarthy, K. D., 265 Araki, T., 395, 559 Dorewe, V. A. C., 239 Jando, G., 909 McKanna, J. A., 441 Aravagiri, M., 473 Duan, S., 767 Jenck, F., 901 Melvin, J. L., 411 Arévalo, R., 7, 783 Dube, M. G., 865 Jennings, I., 949 Mera, T., 617 Armstrong, D. L., 503 Dunn, A. J., 807 Jiang, M., 871 Meredith, M., 75, 111 Asamoto, S., 37, 141, 157 Johansen, P. A., 949 Miller, L. G., 905 Azain, M. J., 853 El-Ridi, M., 703 John, S. M., 285 Minitz, M., 511 Endo, S., 519, 685 Juang, H.-H., 553 Miselis, R. R., 95 Badura, L. L., 231 Engel, J. A., 173 Junien, J. L., 135 Mobley, P. L., 289 Barnes, K. L., 813 Ennis, M., 871 Juraska, J. M., 493 Monroe, S., 925 Barraco, R., 703 Ergene, E., 703 Mora, F., 359 Barski, J.-J., 831 Exposito, I., 359 Kaatz, K. W., 697 Moreau, J.-L., 901 Bazzett, T. J., 697 Kalra, P. S., 865 Moriizumi, T., 193 Behbehani, M. M., 871 Fabre, C., 135 Kalra, S. P., 865 Morimoto, A., 189 Belknap, J. K., 337 Fahn, S., 81 Kamara, A. K., 355 Morimoto, K., 189 Berberich, S., 667 Fang, J., 617 Kamara, K. S., 355 Mullen, B. J., 853 Berman, R. F., 345 Ferris, C. F., 681 Kant, G. J., 129 Murakami, N., 189 Bing, G., 285 Ffrench-Mullen, J. M. H., 221 Kapcala, L. P., 553 Murase, K., 559 Blatteis, C. M., 27 File, E., 381 Karadi, Z., 909 Muro, M., 883 Blazquez, E., 359 Frank, C., 847 Kato, H., 395, 559 Murray, C. E., 473 Blomavist, O., 173 Fregly, M. J., 389 Kelley, A. E., 247, 675 Myslobodsky, M. S., 511 Bluthé, R.-M., 897 Fujishita, M., 141 Kesner, R. P., 345 Bowers, B. J., 57 Furusawa, K., 69 Kigar, D. L., 441 Nadelhaft, I., 651 Boyeson, M. G., 435 Furuyama, F., 795 Kim-Hong, J., 493 Naitoh, M., 45 Bradley, D., 703 Klis, D., 643 Nakai, Y., 821, 943 Brankack, J., 837 Gallagher, A. W., 199 Kofman, O., 511 Nakamura, A., 37, 141 Brifion, J. G., 783 Garcia-Ojeda, E., 783 Kofuji, P., 119 Nencini, P., 401 Bronzetti, E., 847 Gelerstein, S., 541 Kogawa, T., 45 Nespor, S. M., 129 Bueno, L., 135 Geller, H. M., 795 Kogure, K., 395, 519, 559, 659, Newman, M. E., 1 Burt, D. R., 119 Ghasemzadeh, M. B., 891 685 Nicolaidis, S., 525 Byrnes, J. J., 905 Ginn, S. R., 635 Koivisto, E., 837 Niglio,T., 847 Giraudo, S. Q., 853 Koizumi, K., 581 Nishijo, H., 519, 685 Cadet, J. L., 81, 699 Gopal, V. B., 699 Kopcik, J. R., 493 Nishino, H., 795 Calcagnetti, D. J., 843, 859 Gorka, D., 831 Krause, M., 831 Numan, R., 643 Caporali, M. G., 847 Greenblatt, D. J., 905 Krobert, K. A., 435 Nunez, A. A., 225, 231 Carroll, E. W., 411 Griebel, G., 901 Kubota, Y., 479 Castonguay, T. W., 355 Grunberg, N. E., 129 Kuhn, D. M., 949 Ochiai, H., 943 Chahl, L. A., 199 Gue, M., 135 Kujirai, K., 81 Ogata, N., 691 Chai, C. Y., 15, 573 Kumai, T., 69 Ohya, A., 773 Chambers, J. P., 499 Haefely, W. E., 901 Kumazaki, M., 795 Okamoto, K., 795 Chandler, S. D., 871 Hajnal, A., 909 Kuo, J. S., 15 Oltmans, G. A.,329 Chapman, M. A., 473 Hamann, S. R., 507, 605 Kuze, S., 519, 685 Onimaru, H., 879 Chapman, M. E., 931 Hamba, M., 883 Ono, T., 519, 685 Chen, M., 541 Hansson, E., 297 Lahtinen, H., 837 Onodera, H., 659 Cheung, K. S., 515 Hara, H., 659 Lara, J., 783 Oomura, Y., 767, 795 Chronister, R. B., 931 Hashitani, T., 795 Lasiter, P. S., 407 Orsini, J. C., 503 Clark, K. B., 319 Hatton, G. I., 209 Laviola, G., 609 Osaka, T., 581 Coenen, A. M. L., 515 Hattori, T., 193 Lemire, M., 427 O’Toole, L. A., 337 Combs, D. L., 289 Haycock, J. W., 931 Lénard, L., 909 Cooper, T. B., 699 Hergueta, S., 427 Lendvai, B., 369 Palermo-Neto, J., 239 Cotton, R. G. H., 949 Hertz, L., 303 Leung, E., 479 Paredes, R. G., 125 Covenias, R., 529 Hinman, D., 179 Lewin-—Kowalik, J., 831 Parizon, M., 703 Cuadrado, M. I., 529 Hisamitsu, H., 883 Lewis, J. A., 667 Peeters, B. W. M. M., 515 Cunninghan, S. T., 675 Hisamitsu, T., 141, 617 Li, Y. J., 147 Perumal, A. S., 699 958 INDEX 959 Peterson, G. M., 635 Salander, M. K., 567 Sutin, J., 277 Wang, S., 15 Phelps, C. P., 865 Salm, A. K., 265 Szigethy, E. M., 813 Ward, R., 427 Phillips, T. J., 337 Sandor, P., 909 Watanabe, T., 189 Pick, C. G., 363, 609 Sandor, N. T., 369 Tabuchi, E., 519, 685 Wayner, M. J., 15, 499, 503 Pickel, V. M.,257 Santana, C., 7 Takeshige, C., 37, 141, 157, 617 Wehner, J. M., 57 Pimpinella, G., 401 Sanz, B., 359 Tanaka, K., 45 Weidner, C., 427 Plata-Salaman, C. R., 221 Sato, T., 617 Tardif, R., 345 Weiss, M. L., 209 Satoh, S., 45 Tarrasch, R., 511 Weng, C.-F., 553 Scalzo, F. M., 449 Tatebayashi, H., 691 Widmer, U., 901 Raygada, M., 129 Schechter, M. D., 843 Taylor, R. B., 499 Williams, R.,449 Relton, J. K., 243 Schengrund, C.-L., 917 Thomas, J. R., 567 Wilson, M. A., 165 Ren, T., 589 Schneider, S. K., 493 Throne, L. C., 247 Witelson, S. F., 441 Reperant, J., 427 See, R. E., 473 Tordzro, W. K., 699 Wu, W.C., 15 Riekkinen, P. J., 837 Seerley, R. W., 853 Torres, G., 51 Riley, P. J., 389 Seymoure, P., 493 Toyomaki, Y., 795 Ringler, N. J., 917 Alm, L., 27 Shaham, Y., 129 Tramu, G., 529 Rio, J.-P., 427 Shao, Y., 277 Trimble, C., 499 Rivier, C., 51 Yamaoka, M., 69 Shiekhattar, R., 891 Trombka, D., | Rodriguez, M., 7 Yamashita, H., 581 Shimizu, N., 767 Rogel-Fuchs, Y., 1, 363 Yanai, J., 1, 363, 609 Shioda, S., 821 Valdes, J. J., 499 Rogue, P., 469 Yang, J. M., 573 Shipley, M. T., 871 Valeri, P., 401 ROnnbick, L., 297 Yen, C. T., 15 Shurtleff, D., 567 Vera, P. L., 651 Rosenberg, P. A., 315 Yin, T. H., 573 Sieron, A. L., 831 Vida, I., 909 Rothwell, N. J., 243 Yinon, U., 541 Simon, J. R., 147 Vincendon, G., 469 Rowland, N. E., 389 Young, J. K., 375 Sisk, C. L., 231 Vincent, S. R., 479 Rozelle, A., 389 Youngstrom, T. G., 225 Smithson, K. G., 209 Vizi, E. S., 369 Ryan, L. J., 319 Sdderpalm, B., 173 Vossen, J. M. H., 515 Soliman, K., 449 Zahalka, E. A., 1, 363 Sagar, S. M., 589 Stires, C., 681 Walker, J. M., 419 Zangrossie, Jr., H., 381 Sagratella, S., 847 Stone, E. A., 255, 285 Wallace, D. R., 459 Zhang, Y., 285 Sahu, A., 865 Sa, ©. &.,.15 Wang, J. B., 119 Zhou, X. R., 795 Sakata, Y., 189 Sullivan, D. A., 411 Wang, Q.-P., 943 Zhu, S. M., 81 Reproduced with the permission of Pergamon Press Inc., by University Microfilms Inc. Duplication or resale without permission is prohibited.